TATA Health International Holdings (1255) Fair Value & Analysis
Consumer Cyclical · HK · Market cap HK$874M
Fair value as of: Aug 13, 2026
From 7 valuation models · updated 2 days ago
Share price −17.0% over the past month.
A solid business, but screening 45% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (HK$1.51). The favourable scenario is already priced in.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- Solid but not exceptional quality (59/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range HK$0.2800 – HK$8.20 · fair‑value band HK$0.9100 – HK$1.51 · the HK$2.20 price screens above the HK$1.21 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
TATA Health International Holdings (1255) currently trades at HK$2.20, while our model-based Fair Value estimate is HK$1.21, implying the stock looks roughly 45.0% overvalued today. The Quality Score stands at 59/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, TATA Health International Holdings generated revenue of HK$99.8M at a net margin of 13.4%. Revenue grew 0.5% year over year. Net debt stands at HK$7.9M. The stock trades on a trailing P/E of 72.0 (as of Jul 2, 2026). Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$0.9100 (bear case) to HK$1.51 (bull case); at HK$2.20, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 42% below its 52-week high, currently above its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 10% fair-value upside, at -45%, 1255 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 7 models by family
Widest divergence: DCF Models (HK$0.9900) versus Dividend Discount (HK$0.1600). Highest evidence: Gordon GGM (70).
Notify me when 1255 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 56 · Market factors (momentum, volatility) 58
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
TATA Health International Holdings Limited, an investment holding company, engages in the wholesale and retail of footwear products in Hong Kong, and Macau. The company operates through Trading of Footwear Products, Trading of Healthcare Products, Financial Services, and Online Medical Services segments. The company was formerly known as S.
Full company description
TATA Health International Holdings Limited, an investment holding company, engages in the wholesale and retail of footwear products in Hong Kong, and Macau. The company operates through Trading of Footwear Products, Trading of Healthcare Products, Financial Services, and Online Medical Services segments. The company was formerly known as S. Culture International Holdings Limited and changed its name to TATA Health International Holdings Limited in November 2020. TATA Health International Holdings Limited was incorporated in 2013 and is headquartered in Kwai Chung, Hong Kong. TATA Health International Holdings Limited is a subsidiary of Shang Ying Financial Holding Co., Limited.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
TATA Health International Holdings reported revenue of HK$99.8M in FY2025 versus HK$161M in FY2021, a compound −11.3%/yr. Reported net income was HK$13.4M in FY2025.
1255 screens 45% overvalued. Compare with NIKE, Inc →
Peer Group
Footwear & Accessories · 93 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Footwear & Accessories median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Footwear & Accessories stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| NIKE, Inc NKE | $40.51 | $35.63 | -12% |
| adidas AG 1ADS | €158.15 | €65.71 | -58% |
| Deckers Outdoor Corporation DECK | $93.84 | $125.16 | +33% |
| On Holding ONON | $30.91 | $17.53 | -43% |
| Zhejiang China Commodities City Group 600415 | ¥11.81 | ¥13.03 | +10% |
| Birkenstock Holding BIRK | $36.74 | $44.59 | +21% |
| Crocs, Inc CROX | $130.61 | $203.65 | +56% |
| Huali Industrial Group 300979 | ¥36.73 | ¥51.36 | +40% |
| PUMA SE PUM | €26.69 | €10.57 | -60% |
| Yue Yuen Industrial (Holdings) Limited 0551 | HK$13.64 | HK$4.04 | -70% |
Compare TATA Health International Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is TATA Health International Holdings (1255) overvalued or undervalued?
What is the fair value of 1255?
What is the quality score of 1255?
What is the revenue of TATA Health International Holdings (1255)?
What is the net profit margin of 1255?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track TATA Health International Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.